Polar headgroups of free glycosyl-phosphatidylinositol (GPI) lipids or protein-bound GPI membrane anchors have been shown to exhibit insulin-mimetic activity in different cell types. However, elucidation of the molecular mode of action of these phospho-inositolglycan (PIG) molecules has been hampered by 1) lack of knowledge of their exact structure; 2) variable action profiles; and 3) rather modest effects. In the present study, these problems were circumvented by preparation of PIG-peptides (PIG-P) in sufficient quantity by sequential proteolytic (V8 protease) and lipolytic (phosphatidylinositol-specific phospholipase C) cleavage of the GPI-anchored plasma membrane protein, Gce1p, from the yeast Saccharomyces cerevisiae. The structure of the resulting PIG-P, NH 2 -Tyr-Cys-Asn-ethanolamine-PO 4 -6(Man1-2)Man1-2Man1-6Man1-4GlcNH 2 1-6myo-inositol-1,2-cyclicPO 4 , was revealed by amino acid analysis and Dionex exchange chromatography of fragments generated enzymatically or chemically from the neutral glycan core and is in accordance with the known consensus structures of yeast GPI anchors. PIG-P stimulated glucose transport and lipogenesis in normal, desensitized and receptor-depleted isolated rat adipocytes, increased glycerol-3-phosphate acyltransferase activity and translocation of the glucose transporter isoform 4, and inhibited isoproterenol-induced lipolysis and protein kinase A activation in adipocytes. Furthermore, PIG-P was found to stimulate glucose transport in isolated rat cardiomyocytes and glycogenesis and glycogen synthase in isolated rat diaphragms. The concentration-dependent effects of the PIG-P reached 70 -90% of the maximal insulin activity with EC 50 -values of 0.5-5 M. Chemical or enzymic cleavages within the glycan or peptide portion of the PIG-P led to decrease or loss of activity. The data demonstrate that PIG-P exhibits a potent insulin-mimetic activity which covers a broad spectrum of metabolic insulin actions on glucose transport and metabolism. (Endocrinology 138: 3459 -3475, 1997) T HE POSSIBILITY of existence of soluble mediators for metabolic insulin actions in fat and muscle cells has been raised in analogy to the regulation of glycogen storage and mobilization in the liver by ␤-adrenergic hormones via the second messenger, cAMP (1). During the past 20 yr, some evidence has accumulated which seems to be compatible with this concept. 1) Treatment of plasma membranes from insulin-sensitive cells with phospholipases generated soluble small molecular mass substances exerting some insulinmimetic activity. 2) Treatment of fat, liver, and muscle cells with insulin led to the release of small soluble and anionic substances, which in turn reproduced some of the metabolic actions of insulin when exposed to intact cells, e.g. increase of oxidative and nonoxidative glucose metabolism, inhibition of lipolysis (for reviews see Refs. 2-6).
T HE POSSIBILITY of existence of soluble mediators for metabolic insulin actions in fat and muscle cells has been raised in analogy to the regulation of glycogen storage and mobilization in the liver by ␤-adrenergic hormones via the second messenger, cAMP (1) . During the past 20 yr, some evidence has accumulated which seems to be compatible with this concept. 1) Treatment of plasma membranes from insulin-sensitive cells with phospholipases generated soluble small molecular mass substances exerting some insulinmimetic activity. 2) Treatment of fat, liver, and muscle cells with insulin led to the release of small soluble and anionic substances, which in turn reproduced some of the metabolic actions of insulin when exposed to intact cells, e.g. increase of oxidative and nonoxidative glucose metabolism, inhibition of lipolysis (for reviews see Refs. 2-6).
Analytical and metabolic labeling studies indicated the presence of inositol, glucosamine, mannose, galactose, and phosphate in these soluble mediators. Chemical and enzymatic modifications have suggested that they consist of a core structure of phosphoinositol, glycosidically linked to nonacetylated glucosamine, which is itself coupled to additional monosaccharides of varied composition (for a recent review see Ref. 7) . Two different mediators were separated by Cheng and co-workers by sizing columns or by ion exchange resins (8) . Upon chemical analysis, both mediators were shown to be phosphoinositolglycan (PIG) compounds, as previously reported, but they contained two different inositols and amino sugars.
With the first elucidation of the complete structure of a GPI lipid, the membrane anchor of the variant surface glycoprotein, VSG, from Trypanosoma brucei, structural similarity was recognized between the polar headgroup of a GPI membrane protein anchor consisting of a highly conserved glycan core with myo-inositol, nonacetylated glucosamine, and three mannose residues in characteristic glycosidic linkage (for a review, see Ref. 9) , and the PIG substances with insulinmimetic activity identified so far. This concept gained additional attractiveness by a putative straightforward mode of generation of these molecules by a single lipolytic and/or double lipolytic/proteolytic processing from free GPI lipids and/or GPI membrane protein anchors of the plasma membrane, respectively, which would serve as inactive precursors (for reviews see Refs. 2, 7, 10, 11) . In fact, it was known for many years that treatment of insulin-sensitive cells with certain proteases or phospholipases induces some metabolic effects that resemble insulin action to a limited degree. Compatible with these findings was the demonstration that insulin induces release of a set of GPI-anchored plasma membrane proteins from the surface of 3T3 adipocytes (12, 13) , isolated rat adipocytes (14) , BC 3 H1-myocytes (15, 16) and hepatoma cells (17) and from membranes of skeletal muscle (18) via activation of a GPI-specific phospholipase and/or protease. Further evidence has accumulated for an involvement of regulated GPI metabolism in metabolic insulin signaling: 1) An antibody raised against a degalactosylated glycan fragment derived from the GPI membrane anchor of VSG from Trypanosoma brucei selectively inhibited some actions of insulin in intact BC 3 H1 myocytes (19) . 2) Mutant K562 erythroleukemia cells that exhibit insulin-stimulated receptor and IRS-1 tyrosine phosphorylation but are totally deficient in GPI synthesis were completely unresponsive to insulin regarding stimulation of glycogen synthesis (20) . 3) PIG structures exhibit acute hypoglycemic activity in normal and streptozotocin diabetic rats (21, 22) and can be isolated from normal subjects and in reduced amounts from type II diabetic patients (23) .
However, from the beginning the GPI mediator concept was faced with two major problems: 1) The exact structure of the putative GPI cleavage products remained unknown. 2) Systematic investigations on the range of metabolic actions covered by a given chemically defined molecule and on their molecular mechanism of action were lacking. Most studies were performed with impure and chemically heterogenous preparations preventing exact determinations of the concentrations required and were restricted to single or a few selected assays for metabolic insulin actions, only.
These problems may be circumvented by preparation of PIG molecules from a defined source available in sufficient amounts, i.e. by proteolytic/lipolytic digestion in vitro of a single purified GPI-anchored protein. This approach for obtaining chemically defined PIG-peptides (PIG-P), linked via a phosphoethanolamine bridge to one or a few amino acids derived from the carboxyl terminus of the protein moiety, was used in two previous studies. 1) A pronase fragment was prepared from the trypanosomal soluble (PI-specific phospholipase C-degraded) VSG, consisting of the PIG coupled to the carboxyl terminal amino acid of VSG, aspartate (24) . This PIG-P specifically and concentration-dependently inhibited isoproterenol-induced lipolysis in isolated rat adipocytes, liver microsomal glucose-6-phosphatase and cytosolic fructose-1,6-bisphosphatase in a cell-free system as well as gluconeogenesis in isolated hepatocytes. However, high concentrations of the fragment (100 -200 m for maximal effects, EC 50 -values of 62-130 m) were required and their potency relative to that of insulin was not stated (24) . 2) Digestion with PI-specific PLC of the proteinase K-fragment of GPIanchored human erythrocyte acetylcholinesterase yielded a PIG linked to glycine (25) . This PIG-P concentration-dependently antagonized the glucagon-stimulated activation of glycogen phosphorylase in intact rat hepatocytes. However, the cells used displayed limited insulin sensitivity, only, with insulin as well as the PIG-P (10 m) reducing the glucagon response by 20 -30% at maximum (25) . In addition, both studies were restricted to the analysis of inhibitory effects of insulin and PIG-P on glucose and lipid metabolism.
Thus, it seemed useful to reevaluate the potential insulinmimetic activity of PIG-P of known structure with respect to stimulatory effects of insulin on glucose and lipid metabolism. This was also justified by the fact that despite great efforts by numerous laboratories regulation of glucose transport, glycogen and lipid synthesis as well as of lipolysis by insulin via affecting the phosphorylation/dephosphorylation state of key metabolic enzymes remains largely unclear so far, leaving open a putative role of soluble PIG-P in mediating these processes (for a review, see Ref. 26) .
We decided to prepare chemically defined PIG-P from a GPI-anchored protein from the yeast Saccharomyces cerevisiae, the glycolipid-modified cAMP-binding ectoprotein, Gce1p, for the following reasons: 1) Albeit Gce1p is a minor plasma membrane protein of yeast (27) (28) (29) , it can be isolated and purified in quantities sufficient for subsequent proteolytic and lipolytic cleavages in vitro.
2) The structure of the resulting PIG-P has been elucidated (M. Knauf, S. Petry, W. Frick, K. Sauber, manuscript in preparation).
3) The GPI anchor of Gce1p is susceptible to lipolytic/proteolytic processing in vivo during glucose-induced biosynthesis of the cell wall form of Gce1p (30, 31) . PIG-P of similar or identical structure compared with the prepared ones should be generated in vivo, which may have signaling function. 4) A GPIanchored protein homologous to Gce1p in yeast has been identified recently in cultured (13) and isolated adipocytes (32) , which is lipolytically cleaved in response to insulin (13, 14) . 4) GPI membrane protein anchors of yeast and higher eucaryotes possess identical glycan cores and phosphoethanolamine linkages to the carboxyl terminal amino acid of the protein moiety (33, 34) . The only structural differences came from carbohydrate side chains branching off the common glycan cores. The presented work demonstrates that the chemically defined PIG-P obtained from yeast Gce1p exerts a broad spectrum of potent stimulatory effects on glucose and lipid metabolism in isolated rat adipocytes, cardiomyocytes, and diaphragms and offers a method for preparation of sufficient amounts of PIG molecules, which should facilitate studies on their molecular mechanism of action as well as on their potential use as antidiabetic drug. 14 C]glucose (20 mCi/mmol) were purchased from Biotrend (Kö ln, Germany); collagenase (Worthington CLSI, 190 U/mg) was provided by Biochrom (Berlin, Germany) for isolation of adipocytes and by Serva (Heidelberg, Germany) for isolation of cardiomyocytes; semisynthetic human insulin (I81 0182) and ␤-amidotaurocholate were obtained from the pharmaceutical synthesis department of HMR, Hoechst AG (Frankfurt a.m., Germany); adenosine deaminase (bovine intestine), V8 protease (Staphylococcus aureus) and pronase were from Calbiochem (Bad Soden, Germany); ␣-mannosidases (Aspergillus phoenicis, Jack bean) and PI-specific PLC (Bacillus cereus) were provided by Boehringer Mannheim (Mannheim, Germany); BioGel-P4 and ion exchange resins were from Bio-Rad Laboratories (Munich, Germany); cAMP Sepharose, octyl/phenyl Sepharose CL-4B, Sephacryl S-200, Mono Q and Sephadex LH-20 were bought from Pharmacia Biotech (Freiburg, Germany); Wistar rats were delivered from the animal breeding station of Hoechst AG (Kastengrund, Germany).
Materials and Methods Materials

Purification of Gce1p
Gce1p with uncleaved GPI anchor was purified from lactate-grown yeast cells (strain W303 1A, MATa, can R 1-100, ade2 -1, his3-11, 15, leu2-3, 112, trp1-1, ura3-1) (27) . Ten liters of yeast culture (3 ϫ 10 8 cells/ml) were combined with 50 ml suspension of yeast cells (5 ϫ 10 7 cells/ml) that had been metabolically labeled with myo- [ 3 H]inositol (29) to allow monitoring of the purification of Gce1 protein and of the PIG-P derived from it. After conversion of the yeast cells into spheroplasts by digestion with Zymolyase 20,000, plasma membranes were prepared, purified by Ficoll gradient centrifugation (30) , and solubilized in TEB [25 mm Tris/HCl, pH 7.4, 0.5 mm EDTA, 1 mm dithiothreitol (DTT), 20 mm KCl, 0.1 mm phenylmethylsulfonylfluoride (PMSF), soy bean trypsin inhibitor (10 g/ml), 10 m leupeptin, 1 mm iodoacetamide, 5% glycerol, 0.35% ␤-amidotaurocholate (35)] at 2-3 mg protein/ml. A previous study has demonstrated that extraction of membranes with the detergent ␤-amidotaurocholate results in a considerable enrichment of GPIanchored proteins toward integral membrane proteins compared with other detergents (e.g. octyl glucoside) that are commonly used for solubilization of GPI-anchored proteins (35) . After the initial solubilization of Gce1p (recovery 80 -90% of total amount), the following purification steps were performed with TX-100 (see below). The solubilized plasma membranes were diluted with 10 volumes of ice-cold TX-114 (2%), 25 mm Tris/HCl (pH 7.4), 150 mm NaCl, the samples were subjected to phase separation. Gce1p contained in the detergent-enriched phase (two times reextracted) was purified by gel filtration chromatography on Sephadex S-300, affinity chromatography on N 6 -(2-aminoethyl)-cAMP Sepharose (elution with TEB containing 0.1 mm cAMP) and phenyl Sepharose chromatography (elution with the above buffer containing 0.75% TX-100 instead of ␤-amidotaurocholate). Elution from the columns of [ 3 H]inositol-labeled plasma membrane proteins and of a purified [
14 C]inositol-labeled Gce1p marker protein was followed in parallel by monitoring on line the 3 H-and 14 C-radioactivity. The partially purified Gce1p was precipitated with polyethylene glycol 4000 (final concentration 12%). Analysis of a small sample by SDS-PAGE and fluorography revealed the presence of a single radiolabeled band at 54 kDa, only, which comigrated with authentic photoaffinity-labeled Gce1p (for a see comparison Ref. 36) . This demonstrated that Gce1p has been prepared to radiochemical homogeneity and was the only protein in the preparation modified with a GPI anchor. According to binding of [ 3 H]cAMP, Gce1p was enriched 200-to 500-fold (5-10 nmol cAMP bound per mg protein) compared with total yeast membranes.
Preparation and purification of the PIG-P
Digestion with V8 protease. The precipitated and washed (two times with 0.8% polyethylene glycol 4000) Gce1p (400 -500 nmol corresponding to 250,000 to 450,000 dpm) was dialyzed against water, reduced in volume (Speedvac concentrator) and solubilized in 3 ml of 0.1 m Hepes/KOH (pH 8.0), 20 mm CaCl 2 , 0.5 mm DTT, 0.5% TX-100, 30 mg/ml V8 protease (Staphylococcus aureus). After incubation for 10 h at 50 C, a second aliquot of V8 protease and SDS (final concentration, 1%) was added and the digestion continued for 10 h. The digestion mixture was boiled (15 min), centrifuged (10,000 ϫ g, 10 min) and applied to a Sephacryl S-200 column (1.5 ϫ 90 cm) equilibrated in 20 mm sodium phosphate (pH 7.0), 250 mm KCl, 0.1% TX-100, 0.5 mm DTT. The elution of material during this and the following chromatographic runs was followed by measurement of 3 H-radioactivity (Ramona Raytest on-line radioactivity monitor), UV absorption (A 220 ) and insulin-mimetic activity according to stimulation of lipogenesis for each fraction. The 3 H-labeled anchor-containing GPIpeptide had an elution volume of 0.41 relative to the solvent marker K 2 Cr 2 O 7 .
Gel filtration. The peak fractions were pooled, concentrated to 300 l, mixed with 1.2 ml of ice-cold formic acid, and applied to a water-cooled (4 C) Sephadex LH-60 column (1.5 ϫ 65 cm) equilibrated in ethanol, 88% formic acid (3:1, by vol.). One-milliliter fractions were collected, immediately neutralized with NaOH, and measured for 3 H-radioactivity. (A control experiment confirmed that the use of formic acid does not cause cleavage of inositol-1,2-cyclic phosphate, presumably due to the short running time [less than 10 min] and low temperature of the chromatographic procedure. Decyclization of inositol-1,2-cyclic phosphate as induced by treatment with HCl at high temperature [see below] could be followed as a shift in the elution profile during SAX anion exchange chromatography). The major radiolabeled digestion product had an apparent molecular mass of about 2 kDa relative to peptide standards. Fractions 83-100 were pooled, supplemented with NaCl (final concentration, 150 mm) and TX-114 (final concentration, 2%), incubated on ice (15 min) and centrifuged (10,000 ϫ g, 10 min, 4 C). The supernatant was removed and warmed up to 37 C for 10 min to induce phase separation. After centrifugation (10,000 ϫ g, 5 min, 30 C), the aqueous phase was removed. The remaining TX-114 phase containing about 85% of the 3 H-radioactivity was washed two times by addition of the same volume of 100 mm Tris/HCl (pH 7.8), 1 mm EDTA, 0.5 mm DTT and a mix of protease inhibitors (see above).
Octyl Sepharose chromatography. The sample was extracted with an equal volume of water-saturated 1-butanol. The butanol phase was acidified and adjusted to 5% 1-propanol, 100 mm ammonium acetate (pH 5.5). After heating (5 min, 100 C) and centrifugation (10,000 ϫ g, 10 min), the supernatant was applied (2 ml/h) to a column (2.5 ϫ 60 cm) of octyl Sepharose CL-4B equilibrated in 5% 1-propanol, 100 mm ammonium acetate (pH 5.5). The column was washed with 300 ml of equilibration buffer and eluted with a linear gradient of 5-100% propanol in water (10 ml/h) over 800 ml. Eight-milliliter fractions were collected and measured for radioactivity.
3 H-radioactivity eluted between 34 -38% 1-propanol (as determined by the refractive index). The peak fractions 71-79 were pooled, concentrated by evaporation, freeze-dried, and redissolved in 8 ml of 5% 1-propanol. The purification on octyl-Sepharose was repeated once and the eluted radiolabeled material was lyophilized.
Digestion with PI-specific PLC. The sample was dissolved in 200 l of 20 mm Tris/acetate (pH 7.4), 0.1% ␤-amidotaurocholate, 1.5 U PI-specific PLC (Bacillus cereus) and incubated for 8 h at 25 C and following addition of further 5 U of PI-specific PLC for 16 h at 40 C under toluene atmosphere (head-over rotation). After addition of 0.3 ml water, the digest was extracted three times with 0.5 ml TX-100 (20%) to remove toluene. After phase separation, residual toluene was removed from the aqueous phase under a stream of N 2 . The aqueous phase was subjected to TX-114 partitioning as described above. After phase separation the aqueous phase was passed through a 2.5-ml column of AG50X12(H ϩ ), and then eluted with 1 ml H 2 O. The eluate was dried, dissolved in 100 mm ammonium formate (pH 2.8), and loaded onto a 5-ml Dowex 50W-X8 (100 mesh) cation exchange resin column, equilibrated in 100 mm ammonium formate. The [ 3 H]inositol-containing PIG-P was eluted with the same solvent, lyophilized, dissolved in water and passed through a C18 Sep-Pak column.
BioGel-P4 gel filtration. The sample was chromatographed on BioGel-P4 (400 mesh) in H 2 O containing 2 mm DTT. The column (1.5 cm ϫ 1 m) was held at 55 C with a water jacket and eluted with H 2 O containing 2 mm DTT (12 ml/h) in 1-ml fractions. Fractions 70 -75 were pooled, dried, and dissolved in 25 mm Tris/HCl (pH 8.0). The column was calibrated in glucose units (Glu) using a glucose oligomer standard mix (prepared as described for Dionex chromatography).
SAX anion exchange chromatography. The sample was loaded onto a SAX HPLC anion exchange column (0.5 ϫ 5 cm) and eluted with 10 ml of 40 mm triethylamine-formate (pH 4.8), followed by a linear gradient of 60 ml of 40 -400 mm triethylamine-formate in 0.5-ml fractions. Fractions 93-97 were pooled, dried, and dissolved in 50% methanol.
HPTLC analysis. The sample was applied on Si-60 HPTLC plates that were developed in chloroform, methanol, 30% ammonium hydroxide, 1 m ammonium acetate, H 2 O (180:140:9:8:23, by volume) and monitored for radioactivity using a Berthold radioactivity scanner. The major portion of the radiolabeled material remained at the origin. It was eluted from the scraped silica by sonication in 50% methanol, dried, dissolved in water, and applied onto another Si-60 HPTLC plate that was developed with 1-butanol, ethanol, ammonium hydroxide, H 2 O (2:2:1:2, by volume). The plates were scanned for radioactivity. Fractions 21-26 (corresponding a distance of 21-26 mm from the origin) were scraped from the plate, eluted with methanol, dried, dissolved in H 2 O containing 2 mm DTT and used for a second BioGel-P4 chromatography (see above). Fractions 70 -75 were used for analysis by Dionex chromatography (after chemical and enzymic modification) and of insulin-mimetic activity.
Determination of the concentration
PIG-P were hydrolyzed (6 m HCl, 16 h, 110 C, in heat-sealed capillary tube). The amount of inorganic phosphate (2 mol/molecule) was determined. Tyrosine content (1 mol/molecule) was measured by amino acid analysis after derivatization with phenylisothiocyanate. Dried PIG-P was suspended in H 2 O containing 2 mm DTT at a final concentration of 100 m.
Chemical and enzymic modification of PIG-P
Nitrous acid deamination and sodium borohydride reduction. The dried PIG-P (200,000 dpm) was dissolved in 50 l of 0.1 m sodium acetate (pH 4.0), supplemented with 50 l 0.5 m NaNO 2 , and incubated for 3 h at 25 C. After addition of 20 l 0.8 m boric acid, the mixture was adjusted to pH 10.5 by supplementation of 25-40 l 2 m NaOH. The ("hot") reduction was initiated by addition of 40 l NaB 3 H 4 (36 mm in 0.1 m NaOH) and after 2 h completed (cold reduction) by addition of 100 l NaBH 4 and further incubation for 3 h. The samples were supplemented dropwise with 85 l of acetic acid (50%) and then desalted by passage through 0.4 ml AG50X12(H ϩ ) (elution with water), dried, further purified to remove boric acid (rotary evaporation twice with 0.25 ml of acetic acid:methanol [5:95, by volume], twice with 0.25 ml methanol, twice with 50 l toluene) and finally dissolved in water.
Dephosphorylation with hydrogen fluoride (HF).
The dried sample (deaminated and reduced; 200,000 dpm) was supplemented with 50 l aqueous HF (48%), incubated for 48 h on ice and then transferred to 250 -300 l of frozen saturated LiOH, whereby the final pH has to be adjusted to 3-5. After vortexing, centrifugation and two washing cycles of the pellet fraction with 50 l H 2 O each, the combined supernatants were desalted (passage through 0.2 ml AG50X12(H ϩ ) over AG3X4(OH Ϫ ) over 0.1 ml QAE-Sephadex A25(OH Ϫ ), elution with 2.5 ml water), filtered (0.2 m membrane) and dried (rotary evaporation).
Partial acetolysis. The dried sample (100,000 dpm) was treated with 100 l pyridine, acetic anhydride (1:1) for 30 min at 100 C, and again dried. After addition of 60 l acetic anhydride, acetic acid, sulfuric acid (10: 10:1) and incubation for 12 h at 37 C, the reaction was terminated by supplementation of 25 l pyridine and 1 ml H 2 O.
Decyclization. Dried PIG-P was suspended in 100 mm HCl, incubated at 100 C for 15 min and subsequently immediately placed on ice. After neutralization with NaOH, the samples were dried and used for assay of insulin-mimetic activity. Decyclization was controlled by a shift in the elution profile during SAX anion exchange chromatography.
Digestion with ␣-mannosidases from Aspergillus phoenicis and Jack bean.
A quantity of 0.05 mU or 1 U of enzyme, respectively, was incubated with substrate (50,000 dpm) in 25 l 0.1 m sodium acetate (pH 5.0) for 20 h at 37 C. After heating to 95 C for 10 min the cleavage products were desalted, filtered and dried.
Pronase digestion. Dried PIG-P was suspended in 100 mm NH 4 HCO 3 , 1 mm CaCl 2 and incubated at 37 C two times for 20 h with 1.4 mg pronase/ml each. After addition of 90% formic acid (25 l/ml) and centrifugation (4000 ϫ g, 5 min) the resulting supernatant was filtered (0.2 m membrane), passed over a Dowex 50W-X8 column equilibrated with 100 mm ammonium formate (pH 2.8) and eluted with the same buffer. After neutralization, the samples were dried and used for assay of insulin-mimetic activity.
Dionex anion exchange chromatography
The sample was applied on a Dionex CarboPac PA-1 anion exchange HPLC equilibrated with 0.15 m NaOH/0.15 m NaOH, 0.25 m sodium acetate (95:5) at pH 13. The column was eluted with 0.15 m NaOH and 0.15 m NaOH, 0.25 m sodium acetate from 95:5 (0 min) to 80:20 (50 min) at 0.6 ml/min. The column was calibrated in Dionex units by inclusion of 5 l of a glucose oligomer standard mix (20 mg/ml) prepared by partial acid hydrolysis (0.1 m HCl, 100 C, 5 h) to each run. The internal standards were detected using a pulsed amperiometric detector. The 3 H-labeled fragments were followed by the Raytest Ramona on-line radioactivity monitor.
Mono Q anion exchange chromatography
The filtered (0.45 m membrane) sample in 100 l ionized water was injected into an HR5/5 Mono-Q column. The column was eluted at a flow rate of 1 ml/min with deionized water from 0 -1 min, with a linear gradient to 50% of 350 mm ammonium acetate (pH 5.2) from 1-8 min and with a linear gradient to 100% of the same buffer from 8 to 25 min. A 220 was followed on-line.
Isolation of ventricular cardiomyocytes
Ca 2ϩ -tolerant myocytes were isolated from male Wistar rats (260 -320 g) by perfusion of the heart with collagenase as previously described (37, 38) . The final cell suspension was washed three times with HEPES buffer (130 mm NaCl, 4.8 mm KCl, 1.2 mm KH 2 PO 4 , 25 mm HEPES, 5 mm glucose, 20 g/ml BSA, pH 7.4, equilibrated with oxygen) and incubated in silicone-treated Erlenmeyer flasks in a rotating waterbath shaker at 37 C. After 20 min, CaCl 2 and MgSO 4 (final concentration 1 mm) were added and incubation was continued until further use. Cell viability was checked by determination of the percentage of rod-shaped cells and averaged 90 -95% under all incubation conditions.
Isolation of white adipocytes (according to Ref. 39 with the following modifications)
Male Wistar rats (140 -160 g) were killed by cervical dislocation. Epididymal fat pads were placed in KRH (25 mm HEPES free acid, 25 mm HEPES sodium salt, 80 mm NaCl, 1 mm MgSO 4 , 2 mm CaCl 2 , 6 mm KCl, 1 mm sodium pyruvate, 0.5% BSA) and then washed with KRB (12 mm KH 2 PO 4 , 1.2 mm MgSO 4 , 4.8 mm KCl, 25 mm NaHCO 3 , 120 mm NaCl, 1.4 mm CaCl 2 , 5 mm glucose and 2.5% (wt/vol) BSA, bubbled with 5% CO 2 /95% O 2 ). Each pad was then cut into two to three pieces. Two pieces each were incubated with 1.5 ml of digestion buffer (10 mg collagenase in 9 ml KRB) for 15-30 min at 37 C in a shaking water bath. Released adipocytes were washed two times with KRH by flotation and then diluted to a final volume equal to 20 ml of KRH/g of fat (final titer about 2.5 ϫ 10 5 cells/ml).
Desensitization of adipocytes
Isolated rat adipocytes (10 6 cells) were incubated in 20 ml of HEPESbuffered salt solution (40) containing either 5 mm glucose (normal cells) or 20 mm glucose, 16 mm glutamine, 10 nm insulin (desensitized cells) for 20 h at 37 C under gentle shaking. Thereafter, the cells were washed three times with HEPES-buffered salt solution lacking glucose, glutamine, and insulin, and then incubated in 2.5 ml of KRH (final titer about 3-4 ϫ 10 5 cells/ml) for 15 min at 37 C to allow deactivation of the adipocyte glucose transport system. For trypsin treatment, adipocytes in KRB (1.5 ϫ 10 5 cells/ml) were incubated with 40 g/ml trypsin for 20 min at 37 C under gentle shaking. After addition of 0.4 ml bovine trypsin inhibitor (10 mg/ml) and incubation for 5 min at 20 C, the cells were washed two times and finally suspended in KRH (final titer see above).
Assays for insulin-mimetic activity
The rates for the basal and insulin-stimulated activities determined by the individual assays as outlined below are well within the ranges of published data and are given in the corresponding figure legends each.
Lipogenesis. Lipogenesis was measured as incorporation of [
3 H]glucose into total toluene-extractable lipids according to Ref. 41 with the following modifications. Nine hundred microliters of adipocytes (3.5 ϫ 10 5 cells) in KRH containing 140 m glucose were incubated with insulin or PIG-P in 10-ml scintillation vials for 20 min at 37 C. Lipogenesis was started by addition of 100 l d- [3- 3 H]glucose (4 Ci/ml KRH). After incubation for 60 min at 37 C under an atmosphere of 5% CO 2 /95% O 2 and gentle shaking, 10 ml toluene-based scintillation cocktail was added. The samples were vigorously mixed and counted for radioactivity. dpm values for radiolabeled lipids (as measured in the toluene phase) were corrected for a background value determined for an incubation mixture containing the same amount of [ 3 H]glucose but lacking adipocytes.
Glycerol-3-phosphate acyltransferase. GPAT was assayed as incorporation of [ 3 H]glycerol-3-phosphate into butanol-extractable lipids according to
Refs. 42, 43 with the following modifications. Two milliliters of adipocytes (6 ϫ 10 5 cells) were incubated with insulin or PIG-P for 20 min at 37 C in 10-ml scintillation vials under an atmosphere of 5% CO 2 and shaking (160 cycles/min). Washed cells were homogenized in 500 l homogenization medium containing 25 mm Tris/HCl (pH 7.4), 250 mm sucrose, 2 mm EDTA, 2 mm DTT, 180 mm NaF, 1 mm NaVO 3 , 1 mm benzamidine, 10 g/ml aprotinin, 2 g/ml leupeptin, 0.1 mm PMSF by 10 strokes in a Teflon-in-glass homogenisator. After centrifugation (1,000 ϫ g, 5 min, 4 C) the infranatant below the fat cake was removed and centrifuged (14,000 ϫ g, 20 min, 4 C). The supernatant was recentrifuged (150,000 ϫ g, 60 min, 4 C) to obtain a crude microsomal fraction. The pellet was suspended in 25 mm Tris/HCl (pH 7.4), 250 mm sucrose, 0.5 mm EDTA, 1 mm DTT, 0.1 mm PMSF at 2 mg protein/ml and stored in liquid N 2 until determination of GPAT activity (43) . The assay mixture contained 0.2 mm [
3 H]glycerol-3-phosphate (0.5 Ci), 150 m palmitoylCoA and 100 g microsomal protein in a total volume of 0.5 ml and was incubated for 3 min at 37 C.
Glucose transport in adipocytes. Glucose transport was assayed as uptake of 2-deoxy- . Carrier-mediated glucose transport was then determined using a 10-sec assay period and l-[
14 C]glucose to correct for simple diffusion as described earlier (37, 45, 46) .
Glucose transporter isoform 4 (GLUT4) translocation. Adipocytes (7 ϫ 10 6 ) were incubated in 100 ml of KRH containing 5.5 mm glucose with insulin or PIG-P for 20 min at 37 C under gentle shaking. Washed cells in KRH containing 2 mm KCN were suspended in 55 ml of 20 mm Tris/HCl (pH 7.4), 250 mm sucrose, 1 mm EDTA, 0.2 mm PMSF, 100 m benzamidine, 20 g/ml leupeptin, pepstatin, aprotinin, and antipain each, and homogenized 10-times in a Teflon-in-glass homogenizer. Plasma membranes and low density microsomes were prepared as described (47) . GLUT4 was quantitatively immunoprecipitated with rabbit anti-GLUT4 antibodies raised against the carboxyl-terminal 16 amino acids of rat GLUT4 and protein A-Sepharose. The immunoprecipitated GLUT4 was separated by SDS-PAGE and its amount evaluated by immunoblotting with the same antibodies and [
125 I]protein A followed by autoradiography of the dried gel (Kodak X-Omat AR). Quantitation was performed by phosphorimaging of the dried gel (Molecular Dynamics, Storm 840).
Glycogenesis. Glycogenesis was assayed as incorporation of U-[
14 C]glucose into ethanol-precipitable glycogen. Intact hemidiaphragms with rib cage attached were dissected from male Wistar rats and incubated in DMEM (15 ml/hemidiaphragm) containing 10% FCS, 5.5 mm glucose, 1% BSA, 50 U penicillin/ml, 50 g streptomycin sulfate/ml under constant bubbling of O 2 :CO 2 (95:5) for 60 min at 37 C. Subsequently, the diaphragms were incubated with insulin or PIG-P in DMEM (15 ml/ hemidiaphragm) for 30 min at 37 C in the presence of insulin or PIG-P. Washed hemidiaphragms were then incubated with 5 Ci [U- 14 C]glucose in 15 ml KRH containing 2 mm glucose for 20 min at 37 C in the presence of insulin or PIG-P. After blotting and cutting off the rib cage, the hemidiaphragms (80 -100 mg wet weight) were washed, frozen in liquid N 2 , and homogenized in 2 ml of 25 mm Tris-HCl (pH 7.4), 150 mm NaF, 5 mm EDTA, 0.1 mm PMSF in porcelain mortar on ice. One hundred microliters of the supernatant (200 -500 g protein) obtained by centrifugation (10,000 ϫ g, 15 min, 4 C) was used for glycogen determination by precipitation of glycogen with ethanol (43) . 14 C]glucose (4 Ci), 6.7 mg glycogen, 150 mm KF and 0.1 mm/10 mm glucose-6-P. After incubation for 20 min at 30 C, the reaction was terminated by addition of 2 ml of 66% ethanol, 10 mm LiBr (Ϫ20 C), rapid mixing and filtration over prewetted Whatman GF/C glass-fiber discs. The filters were washed five times with 5 ml of 66% ethanol each at 25 C, dried, and measured for radioactivity. Blank values determined by adding the homogenate to tubes containing the complete reaction mixture plus ice-cold ethanol were subtracted from the total values each. The fractional velocity was calculated as described (43) . Measurements of GS activity in homogenates from adipocytes that had been incubated in the presence of 0.1 mm glucose instead of 5 mm glucose (the concentration routinely used) did not reveal significant differences with respect to both the activity ratio and the effect of PIG-P or insulin. Presumably, the dilution of the limited amount of glucose-6-phosphate, which accumulates during incubation with 5 mm extracellular glucose, during the subsequent preparation of the homogenate and the GS assay was high enough to prevent allosteric activation of GS. According to our experience, incubation of the isolated rat adipocytes in the presence of 5 mm glucose has a positive impact on their viability, in general, and insulin sensitivity (glucose transport, glycogen synthesis), in particular.
Glycogen synthase (GS
Lipolysis. Lipolysis was assayed as release of glycerol. One milliliter of adipocyte suspension in KRB (3 ϫ 10 5 cells) was incubated with insulin or PIG-P for 10 min at 37 C under an atmosphere of 5% CO 2 . After addition of 1 m isoproterenol and 1 unit of adenosine deaminase, the incubation was continued for 60 min. Following addition of 200 l of extraction medium containing 120 mm Hepes/KOH (pH 7.4), 6 mm isobutylmethylxanthine, 60 mm EDTA, 180 mm NaF, the cells were homogenized by 10 strokes of a Teflon-in-glass homogenizer. The extract was centrifuged (10,000 ϫ g, 15 min, 4 C). The infranatant below the fat cake was stored in liquid N 2 and used for glycerol determination (43) .
Protein kinase A. PKA was assayed by incorporation of 32 P from [ 32 P]ATP into histone H1. Twenty microliters of the cleared adipocyte extract (see "lipolysis") was added to 80 l of a reaction mixture containing 20 mm 3-(N-morpholino)propanesulfonic acid (pH 7.2), 4 mm DTT, 12.5 mm MgCl 2 , 0.2 mm PMSF, 1 mm isobutylmethylxanthine, 50 m [ 32 P]ATP (2.5 Ci) with or without 1 m cAMP. After incubation for 10 min at 30 C, the reaction mixture was supplemented with 1 ml of ice-cold 20% trichloroacetic acid, 10 mm ATP, 5 mm NaPP i , 100 mm NaF. The precipitates were centrifuged (12,000 ϫ g, 5 min, 4 C) and then dissolved in 100 l of 1 n NaOH. After addition of 1 ml of 20% trichloroacetic acid, 5 mm NaPP i , 10 mm ATP, the precipitates were decanted onto Whatman GF/C glass fiber filters under vacuum prewetted with washing solution (20% trichloroacetic acid, 5 mm NaPP i ). After washing (five times with 3 ml each of washing solution), the filters were dried and counted for radioactivity. Blank values determined by inclusion of 0.6 mg/ml PKA inhibitor from bovine heart into the reaction mixture were subtracted from the total values each. The PKA activity ratio indicating the portion of PKA active at the time-point of homogenization compared with total enzyme content was expressed as the ratio between phosphorylation of histone H1 with and without cAMP.
Miscellaneous procedures
Published methods were used for protein determination (43) , generation of the trifluoroacetic acid (TFA)-fragment from the PIG-P (48), immunoprecipitation and immunoblotting of GLUT4 (47) and immunoprecipitation/immunodepletion of the PIG-P with anti-CRD antibodies (28, 30) .
Results
Preparation, purification, and characterization of the PIG-P
A GPI anchor fragment was prepared from Gce1p, which had been partially purified by gel filtration, cAMP-affinity, and phenyl Sepharose chromatographies. In this preparation, Gce1p was the only GPI-anchored protein present because Gce1p from yeast cells, which had been metabolically labeled with myo- [ 3 H]inositol and added as a tracer to the large-scale culture of unlabeled cells, represented the only radiolabeled band observed after SDS-PAGE and fluorography (data not shown). The unlabeled and 3 H-labeled Gce1p was completely digested with V8 protease from Staphyloccocus aureus to cleave the protein moiety near its carboxyl terminus linked to the anchor. The resulting GPI anchor peptide eluted during gel filtration in the presence of detergent with an apparent molecular mass of about 2 kDa (fractions 83-100; Fig. 1A ). It was then subjected to hydrophobic interaction chromatography on octyl-Sepharose (Fig. 1B) . The radiolabeled GPI anchor peptide eluted as a sharp peak between 34 -38% 1-propanol (fractions 71-79). It was subsequently treated with exogenous PI-specific PLC from Bacillus cereus to remove diacylglycerol from the anchor. After recovery from the aqueous phase of TX-114 partitioning, the [ 3 H]inositol-labeled, polar PIG-P eluted during BioGel-P4 chromatography at a volume corresponding to 8 -8.5 glucose units as the major peak (fractions 70 -75). It was further purified by anion-exchange chromatography on a SAX HPLC column (Fig. 1D ). PIG-P (fractions 93-97) constituted the only peak material with respect to both radiolabel and A 220 and was finally subjected to two successive HPTLC runs. The material migrating as the single radioactive and UV-absorptive spot during the second HPTLC plate (Fig. 1E ) was recovered (fractions 21-26). It was analyzed by BioGel-P4 chromatography (Fig. 1F ) and shown to be radiochemically and spectroscopically pure. The elution behavior (fractions 70 -75) from the column, calibrated with a glucose oligomer standard mix, with a retention time of 8.5 glucose units corresponding to about 1.5 to 1.6 kDa is compatible with the apparent molecular mass of a polar fragment derived from Gce1p by digestion with pronase and bacterial PI-specific PLC (29) . During purification of the V8 protease-fragment from partially purified Gce1p by the successive chromatographies (steps A-F), more than 95% of the total [
3 H]inositol and 99.9% of total material (A 220 ) was removed from the preparation ( Table 1 ). This material presumably consists of proteolytic degradation fragments (peptides, amino acids) from Gce1p itself and from proteins which are not modified with a GPI anchor (see above) and contaminate the Gce1p preparation as well as of lipids associated with the GPI anchor of Gce1p. Previous studies demonstrated that Gce1p can be isolated from yeast plasma membranes in TX-100 insoluble complexes (49) , which in mammalian cells harbor GPI lipids, glycosphingolipids and cholesterol, in addition (for a review, see Ref. 50 ).
After lipolytic cleavage (step C 0 ), about 50% of the total [ 3 H]inositol-labeled material was immunoprecipitated with anti-CRD antibodies. These antibodies primarily recognize the inositol-1,2-cyclic phosphate moiety and to a minor degree some epitopes within the nonacetylated glucosamine and glycan core but fail to react with the uncleaved anchor (28) . Because during further purification only about 25% of this material was proved to constitute the PIG-P, a considerable portion of PIG-like structures harboring [ 3 H]inositol-1,2-cyclic phosphate must have been generated from free GPI lipids during treatment with PI-specific PLC. These contaminants were removed during the subsequent purification steps, C-F 0 , because the last step, F, resulted in no further enrichment of the specific insulin-mimetic activity of the material compared with step F 0 with respect to 1) total [ 3 H]inositol-labeled; 2) anti-CRD-immunoprecipitated [ 3 H]inositol-labeled; and 3) total (A 220 ) materials. This suggests that aromatic amino acid residues/peptide bonds detected by A 220 and the inositol-1,2-cyclic phosphate moiety copurify with the activity. This was also reflected in the loss of activity from the peak materials (steps C-F 0 ) after quantitative immunodepletion with anti-CRD antibodies and protein ASepharose. The portion of insulin-mimetic activity that was not immunodepleted decreased with the degree of purification from about 13% to 2%, suggesting that a portion of inositol-1,2-cyclic phosphate-containing molecules that had been generated by PLC-digestion did not exert insulin-mimetic activity. During purification of the lipolytically digested GPI-peptides, their specific insulin-mimetic activity (assayed as 50% of the maximal insulin-stimulated lipogenesis) was enriched about 30-fold with respect to total material (A 220 ), 3-fold with respect to [ 3 H]inositol and 2-fold with respect to [ 3 H]inositol-1,2-cyclic phosphate if the peak fractions from C 0 were used as starting material for the calculation. About 4% of the total [ 3 H]inositol and 0.1% of A 220 contained in the starting material (step A) was recovered in the final preparation (step F). The gain in purity of the PIG-P preparation during steps C 0 to F was confirmed by an analytical high resolution anion exchange chromatography using a Mono Q column and measurement of A 220 (Fig. 2) . The relative increases in the percentage area of peak material eluting at 2.92-2.98 min (as indicated by an arrow) out of total material from the corresponding step (C 0 [5 Table 1 ). In addition, the peak materials eluting at 2.92-2.98 min contained more than 95% of the [ 3 H]inositol radiolabel of the total materials from step C 0 , D, E and F, each (data not shown). These findings strongly suggest that the peak material (at 2.92-2.98 min) contains the insulin-mimetic activity. Thus, since A 220 is a very sensitive parameter for detection of organic as well as of anorganic substances, the material obtained after the final purification step (F) is assumed to be chemically homogenous.
The apparently low recovery of [ 3 H]inositol during the purification steps C 0 3 F (about 17%) can be explained by a large amount of (phosphorylated) inositol moieties contaminating the PIG-P at stage C 0 that are generated by lipolytic digestion from phosphoinositol lipids copurifying with detergent-solubilized Gce1p. The enrichment of GPI-anchored proteins and phospholipids in detergent-resistant complexes is well documented (49, 50) . This (phosphorylated) inositol- Table 1 ) were subjected to chromatography on a Mono Q column. The elution was followed by measurement of A 220 . The retention times of the major peaks are given. The arrows indicate the peak containing PIG-P (see Results).
containing material obviously did not exhibit significant insulin-mimetic activity (see 3.3-fold enrichment with regard to the amount of [ 3 H]inositol from C 0 3 F). Furthermore, after immunodepletion with anti-CRD antibodies, only a minor portion of insulin-mimetic activity was left in the fractions C 0 (12.8%) 3 F (3.4%) each, whereas the immunodepleted fraction C 0 still contained about 80% of total [ 3 H]inositol (data not shown). This argues for the absence of inositol-1,2-cyclic phosphate in the phosphorylated inositol-containing material contaminating the PIG-P throughout the purification steps C 0 3 F. The decline in the residual insulin-mimetic activity left after immunodepletion during step C 0 3 F reveals the removal of insulin-mimetic activity that is not due to the PIG-P structure and thereby confirms the efficiency of the purification procedure. At the end, more than 96% of the total activity contained in fraction F could be immunoprecipitated with anti-CRD antibodies, i.e. the vast majority of active molecules harbors a terminal inositol-1,2-cyclic phosphate residue.
Structural analysis of the material from step F revealed the presence of components, only, typically for the polar head group of yeast GPI anchors and of the carboxyl terminal tripeptide of Gce1p, Tyr-Cys-Asn (determined by sequence determination using manual Edman degradation) that are covalently linked (data not shown, manuscript in preparation). Determination of free amino groups in the intact PIG-P demonstrated the presence of two such groups per mol of myo-inositol, one belonging to the nonacetylated glucosamine, the other one to the tyrosine residue. Other amino acids (determined after total acid hydrolysis by the ninhydrin method) were not found in the PIG-P preparation. This provides strong evidence that the PIG-P is derived from a single GPI-anchored protein, Gce1p, and demonstrates its chemical homogeneity. Furthermore, the GPI anchor of Gce1p appears to be very closely related to the trypanosomal or vertebrate GPI anchors because, after cleavage by PIspecific PLC, it is recognized by antibodies against the crossreacting determinant of soluble VSG from Trypanosoma brucei. This suggests a structural arrangement of the glycan core constituents of Gce1p in a fashion similar or identical to that of VSG.
The PIG-P obtained after the final purification step F were analyzed by Dionex anion exchange chromatography. For this, they were deaminated by nitrous acid treatment and then reduced with radiolabeled sodium borohydride for replacement of (radiolabeled) inositol-1,2-cyclic phosphate with radiolabeled 2,5-anhydromanitol (AHM). The material was then subjected to aqueous HF dephosphorylation for removal of the terminal phosphoethanolamine moiety. Subsequently, three different chemical or enzymic treatments were performed to specifically cleave off mannose residues before analysis of the size of the degradation fragments radiolabeled at the terminal AHM by Dionex chromatography (Fig. 3) . The radiolabeled HF-fragment was eluted at 3.2 Dionex units corresponding to the neutral glycan core with a single carbohydrate side chain branching off, Man1-2Man1-2Man1-6Man1-4AHM (Fig. 3A) . It thus constitutes the glycan portion of 80% of the whole spectrum of GPI anchors made by yeast cells (34) . The lack of terminal phosphoethanolamine allowed access of mannose-specific exoglycosidases to this structure. ␣-mannosidase (Aspergillus phoenicis) specific for ␣-d-Man(1-2)d-Man glycosidic bonds released a radiolabeled fragment from the deaminated, reduced and dephosphorylated PIG-P eluting at 2.2 Dionex units compatible with the structure, Man1-6Man1-4AHM (Fig. 3B) . ␣-mannosidase (Jack bean), specific for any terminal, nonsubstituted, ␣-d-Man, generated a radiolabeled fragment from the neutral glycan core eluting at 1.0 Dionex units corresponding to a structure completely devoid of the mannose residues, i.e. AHM (Fig. 3C) . Finally, partial acetolysis, which is relatively specific for Man(␣)1-6Man glycosidic bonds (but also cleaves Man(␣)1-4AHM to a minor degree), produced a radiola- 3 H]AHM-labeled cleavage product was treated with HF and then analyzed by Dionex anion exchange chromatography either directly (A; 50,000 dpm applied) or after digestion with ␣-mannosidase from Aspergillus phoenicis (B; 50,000 dpm applied) or Jack bean (C; 30,000 dpm applied) or after partial acetolysis (D; 25,000 dpm applied). Number of Dionex units as indicated above the arrows were derived from the elution behavior of a glucose oligomer standard mix run in parallel with the radiolabeled samples.
beled structure from the neutral glycan core eluting at 1.1 Dionex units consistent with Man1-4AHM as well as a small amount of free radiolabeled AHM (Fig. 3D) . Taken together, the size analysis of the exoglycosidase digestion and partial acetolysis products of the deaminated, reduced and dephosphorylated PIG-P by Dionex anion exchange chromatography is in full agreement with a conserved glycan core structure of the headgroup of GPI anchors common for protozoa and mammals, Man1-2Man1-6Man1-4GlcN1-6inositol-1-phosphate, which is modified with a single Man1-2 branch at the distal mannose residue typical for the 80%-component of total yeast GPI anchors (34) . In addition, this structure was confirmed by 1) NMR spectroscopy of the complete as well as deaminated/dephosphorylated PIG-P (Knauf, M., unpublished results); 2) GC/MS analysis of the chemically or enzymatically treated PIG-P (Petry, S., unpublished results); and 3) GC analysis of the complete GPI anchor peptide generated by pronase digestion of Gce1p (29) . In the latter study, the purified GPI anchor peptide was dephosphorylated with HF, the oligosaccharides hydrolyzed with trifluoroacetic acid, the sugars reduced with NaBH 4 and then acetylated, and the final products separated and identified by GC and amino acid analysis. Using these methods, the stoichiometry of the individual components was determined as follows: ethanolamine: Man: GlcN: inositol ϭ 1.2: 3.9: 1: 1.6.
This chemically homogenous and structurally defined PIG-P was used for assaying a putative insulin-mimetic activity in isolated rat adipocytes, cardiomyocytes, and diaphragms. The yield of pure PIG-P from 100-liter yeast culture was typically 100 -150 nmol (Table 2 ). This amount was sufficient for performing a complete concentrationsresponse curve for a single insulin-mimetic activity with adipocytes (each point with five independent incubations). The assays with diaphragms required larger fermentations of yeast on industrial scale (up to 1000 liters). Gce1p is a low abundance protein with respect to total membrane proteins compared with certain mammalian or protozoal GPI-anchored proteins. However, the possibility of large scale production of a GPI-anchored protein and PIG-P derived thereof by yeast is of great advantage, which obviously represents a prerequisite for a systematic study of the insulin-mimetic activity of PIG structures by performing a multitude of different assays based on various cellular systems over a broad range of concentrations. Previous reports using PIG-P from human erythrocyte acetylcholinesterase and trypanosomal VSG were clearly limited in this respect (Refs. 24, 25; see also first section of this article).
PIG-P stimulates lipogenesis, glucose transport, GLUT4 translocation, and GPAT in normal and desensitized rat adipocytes
First, the effect of PIG-P on lipogenesis in isolated rat adipocytes was studied (Fig. 4) . In normal adipocytes, lipogenesis (performed at low glucose) was stimulated in a concentration-dependent manner by both insulin (up to 22-fold; EC 50 ϭ 0.5 nm) and PIG-P (up to 15.5-fold; EC 50 ϭ 1 m). In adipocytes preincubated in primary culture in the presence of high concentrations of glucose, glutamine and insulin to induce desensitization of the cells toward insulin (40, 47) , the insulin stimulation of lipogenesis was reduced to about 40% of the normal response (10-fold at maximum). In contrast, the maximal responsiveness of the desensitized adipocytes toward PIG-P was significantly less diminished (to about 80% of the normal response) with no apparent change of the EC 50 values. In fact, in desensitized adipocytes, the maximal activation of lipogenesis was higher for PIG-P compared with that for insulin. In adipocytes pretreated with a limited concentration of trypsin to cleave off the insulin binding ␣-subunit of the insulin receptor, insulin completely failed to increase lipogenesis. There was no concomitant impairment of cell viability as confirmed by stimulation of lipogenesis by 1 mm NaVO 3 to about 90% of the maximal insulin effect (data not shown). PIG-P activated lipogenesis to about 80% compared with that of untreated cells with EC 50 -values remaining at 1-2 m. These data provided first hints that 1) PIG-P exerts certain insulin-mimetic effects on isolated rat adipocytes; 2) PIG-P may interfere with the insulin signaling cascade at a site downstream of the putative defect, which is responsible for the desensitization; and 3) PIG-P does not bind to the insulin receptor.
Stimulation of lipid synthesis by insulin is determined mainly by two steps that are under insulin control, glucose transport and esterification of glycerol-3-phosphate by GPAT. GPAT (Fig. 5 ) was activated by insulin in a concentration-dependent manner up to 2.5-fold (EC 50 ϭ 0.5 nm) when assayed with a crude microsomal fraction that had been prepared from incubated normal adipocytes. PIG-P increased GPAT activity in a concentration-dependent manner up to 1.8-fold (EC 50 ϭ 3-5 m) which accounted for 75-85% of the maximal insulin effect. Additional experiments demonstrated that the GPAT activity associated with a crude mitochondrial fraction (14,000 ϫ g-pellet, see Materials and Methods), which in contrast to its microsomal counterpart cannot be inactivated by N-ethylmaleimide, was not affected at all by incubation of the adipocytes with either PIG-P or insulin (data not shown). This is in agreement with TABLE 2. Evaluation of the yield of chemically defined PIG-P obtained from a typical yeast culture
Step Yield
Fermentation 100 liter yeast culture (3 ϫ 10 7 cells/ml) Harvesting of the cells 400 -500 g cells wet weight Cell lysis 35-40 g total protein Cell fractionation 2.5-3 g plasma membrane protein Protein purification 20 -25 mg radiochemically pure Gce1p (400 nmol) Proteolytic cleavage of Gce1p and purification of GPI-peptide 250 -300 nmol GPI-peptide Lipolytic cleavage of GPI-peptide and purification of PIG-P 100 -150 nmol chemically pure PIG-P For details of the procedure see Materials and Methods and footnote to Table 1 .
a previous report on BC 3 H-1 myocytes (42) that the microsomal N-ethylmaleimide-sensitive form of GPAT, but not the mitochondrial N-ethylmaleimide-insensitive one, is under insulin control. Glucose transport (Fig. 6 ) was increased up to 15-fold after incubation of normal adipocytes with both insulin (EC 50 ϭ 0.3 nm) and PIG-P (EC 50 ϭ 1-1.5 m). In desensitized adipocytes, glucose transport activation by insulin was drastically impaired with respect to both maximal responsiveness (5-fold) and sensitivity (EC 50 ϭ 3-4 nm). In contrast, PIG-P stimulated glucose transport to about the same maximal response with slightly elevated EC 50 values (2-2.5 m). In consequence, in desensitized adipocytes the maximal glucose transport activity elicited by PIG-P (at 20 m) exceeded that by insulin about 3-fold. The differential desensitization of the glucose transport system for stimulation by insulin and PIG-P is well correlated to that of lipogenesis (see above). This reflects the fact that at low glucose concentrations (Ͻ0.1 mm) in the incubation medium glucose transport is rate-limiting for lipid synthesis in isolated adipocytes.
The molecular basis for the stimulation of glucose transport by insulin is the increase of cell surface expression of the insulin-sensitive glucose transporter isoform GLUT4 via its translocation from tubulo-vesicular structures of the transGolgi network (low density microsomes) to the plasma membrane (for a review, see Ref. 51 ). Incubation of normal adipocytes with PIG-P led to a concentration-dependent increase of the amount of GLUT4 at the plasma membrane to about 85% of the maximal insulin response (calculated as difference between the stimulated and basal states, respectively, to compensate for small deviations between the basal amounts of GLUT4) and concomitantly to a corresponding decrease of GLUT4 in the low density microsomes (Fig. 7A) . The EC 50 -values for activation of glucose transport and GLUT4 translocation by PIG-P were comparable (2-3 m), whereas the maximal stimulation factor for translocation (about 5-fold) is considerably lower than that for transport (Fig. 7B) . Presumably, this reflects the limited responsiveness of the GLUT4 translocation assay due to contamination of the isolated plasma membranes with low density microsomes as suggested by a similar discrepancy for insulin (about 6-fold stimulation of translocation, see Fig. 7 ). However, an increase of the intrinsic glucose transport activity of GLUT4 by PIG-P in addition to stimulation of GLUT4 translocation cannot be excluded so far.
To confirm the specificity of the insulin-mimetic effects of PIG-P, it was subjected to various chemical or enzymatic procedures, which are known to cause cleavage of either its PIG or peptide portion at defined sites, and then assayed for stimulation of lipogenesis and glucose transport in isolated rat adipocytes (Fig. 8) . Control experiments with equivalent volumes of digestion mixtures lacking PIG-P added to adipocytes before incubation with insulin demonstrated that the dilution of the incubation mixtures was sufficient and the test period short enough to avoid significant interference with insulin signaling (data not shown). Thus, a putative reduction of PIG-P activity in stimulating lipogenesis and glucose transport would most likely be the consequence of the loss of certain structural determinants of the PIG-P. Treatment with nitrous acid at pH 3.5 and subsequent reduction leads to deamination of the nonacetylated glucosamine separating phosphoinositol from the glycan-peptide portion with its terminal AHM. Treatment with aqueous HF causes dephosphorylation, separating the inositolglycan portion from the phosphate and ethanolamine-peptide moieties. Treatment with mild acid cleaves the myo-inositol-1,2-cyclic phosphodi- ester, resulting in PIG-P with terminal inositol-1(2)-monophosphate. Treatment with pronase removes the two terminal amino acids, Tyr, Cys, from the peptide portion resulting in phosphoinositol-glycan-Asn. Treatment with TFA cleaves between the nonacetylated glucosamine and the proximal mannose residue separating phosphoinositol-glucosamine from the glycan-peptide portion with the mannose residues attached. In comparison to the untreated PIG-P, each treatment caused a considerable impairment of the maximal activation (by 10 m PIG-P) of lipogenesis and glucose transport (Fig. 8) . Most efficient were nitrous acid deamination, aqueous HF dephosphorylation, and TFA cleavage with reductions to almost basal values, compatible with cleavage of the PIG-P within its glycan core structure. Opening of the terminal cyclic phosphate moiety resulted in a somewhat lower, but still significant, deactivation to 2-to 3-fold above basal values. Removal of the two amino terminal amino acids from the tripeptide decreased the activity to 50 -60% of that of the untreated PIG-P (see Discussion). Immunodepletion of the PIG-P preparation with anti-CRD antibodies revealed that about 70% of the total insulin-mimetic activity (with respect to stimulation of both glucose transport and lipogenesis) could be removed from the particular lot of PIG-P (used for the experiments of Fig. 8 ). In that lot, the portion of PIG-P molecules harboring the intact inositol-1,2-cyclic phosphate moiety was about 30% of total material, only (due to prolonged storage at pH 6.5) as determined by quantitative and calibrated immunoblotting with anti-CRD antibodies. This means that the specific insulin-mimetic activity of PIG-P with inositol-1,2-cyclic phosphate is about 3.7-fold higher than that of PIG-P with decyclized inositol-monophosphate attached (the remaining portion contained in that lot of PIG-P). This value is in reasonable agreement with the 5.4-fold higher specific activity of the inositol-1,2-cyclic phosphate containing PIG-P as calculated for the PIG-P preparation of the purification scheme (Table 1 ; 11% of total PIG-P molecules did not cross-react with anti-CRD antiserum and contained 3.4% of total insulin-mimetic activity). We conclude that the tripeptide and inositol-cyclic-phosphate moieties at the termini of the PIG-P are not absolutely required for but significantly enhance the insulin-mimetic activity of PIG-P.
PIG-P stimulates glucose transport, glycogenesis, and GS in rat cardiomyocytes and diaphragms
Adipose tissue is usually not regarded as a major site for insulin-dependent glucose disposal and storage. The major portion of the blood glucose is taken up by muscle tissue and stored as glycogen. Therefore, we asked whether PIG-P stimulate glucose transport and glycogen synthesis in insulinsensitive muscle preparations, e.g. rat cardiomyocytes and diaphragms. Rat ventricular cardiomyocytes express a high level of GLUT4, which is translocated to the plasma membrane in response to insulin (38, 46) . This cellular system was used to investigate the effects of PIG-P on initial glucose transport rates in a highly insulin-sensitive primary muscle cell. As presented in Fig. 9 , insulin produced a 3.3-fold stimulation of 3-O-methylglucose transport using maximally effective concentrations of the hormone. Parallel incubations with PIG-P (2 m) showed that they produced a 2.3-fold increase in glucose transport corresponding to 70% of insulin action.
Incubation of intact isolated rat diaphragms with PIG-P stimulated glycogenesis in a concentration-dependent manner up to 2.2-fold corresponding to 75-90% of the maximal insulin effect (elicited by 330 nm; Fig. 10 ). The higher EC 50 value of PIG-P (8 -10 m) required for the isolated diaphragms compared with adipocytes may be muscle-specific or based on a diffusion barrier for the PIG-P to reach (via the endothelium) the individual muscle fibers of the diaphragm. The even more pronounced discrepany of the EC 50 -values for insulin between diaphragm and adipocytes as well as the similarity of the EC 50 -values for PIG-P between cardiomyocytes (see above) and adipocytes favor the latter possibility. The key metabolic enzyme for glycogen synthesis is GS, which is activated by insulin both in an allosteric (via increase of glucose-6-phosphate) and covalent (via dephosphorylation) manner. At low glucose-6-phosphate concentrations (Ͻ0.1 mm), the dephosphoform of GS will be active. GS activity was increased in a concentration-dependent manner upon incubation of intact diaphragms with PIG-P or insulin and subsequent assay of a homogenate fraction in the presence of 0.1 or 10 mm glucose-6-phosphate (Fig. 11) . The increments of the maximal fractional velocity, i.e. the portion of active dephosphoform of GS at the time point of homogenization, were comparable between PIG-P (2.8-fold vs. basal) and insulin (2.6-fold vs. basal). The corresponding EC 50 -values for PIG-P (8 m) and insulin (10 -20 nm) were in good agreement with those for glycogenesis (see above).
PIG-P inhibits lipolysis and PKA activation in rat adipocytes
Inhibition of lipolysis in adipose tissue is one of the most sensitive metabolic insulin actions in vivo. Insulin levels in the low nm-range are sufficient to prevent significant release of fatty acids from the lipid stores and to keep free fatty acid serum concentrations at a low basal niveau in the absence of ␤-adrenergic agonists. We studied whether PIG-P inhibits agonist-stimulated lipolysis in isolated rat adipocytes (Fig.  12) . Upon incubation of adipocytes, insulin and PIG-P reduced in a concentration-dependent manner the rate of isoproterenol-induced lipolysis to almost basal levels and to about 30% above basal, respectively. Compared with the other insulin-mimetic effects of PIG-P on isolated rat adipocytes (see above), the concentration-response curve was shifted to the left (EC 50 ϭ 0.5-0.8 m). The increase of sensitivity of fat cells for the antilipolytic activity of PIG-P corresponds well to the high sensitivity toward insulin (EC 50 ϭ 0.05-0.07 nm), which may be taken as evidence for (in part) similar molecular mechanisms used by PIG-P and insulin for inhibition of hormone-sensitive lipase.
Inhibition of lipolysis by insulin in adipose tissue is thought to be mediated by both cAMP-dependent and independent mechanisms. The dependent one seems to operate via regulation of PKA activity, exclusively, whereas the independent one may directly affect hormone-sensitive lipase. We studied the effect of PIG-P on the agonist-induced increase of the activity ratio of PKA. For this, total homogenates, which had been prepared from isolated rat adipocytes after successive incubation with PIG-P or insulin and isoproterenol, were assayed for PKA activity in the presence or absence of cAMP (Fig. 13) . Incubation of rat adipocytes with PIG-P before treatment with isoproterenol led to a concentration-dependent decline of the PKA activity ratio from the maximal isoproterenol-induced value (set at 1) to 0.25-0.30, which corresponded to about 70% of the maximal insulin effect. The EC 50 value of PIG-P for inhibition of PKA (0.3-0.5 m) was in good correlation to that for inhibition of lipolysis (see Fig. 12 ). This suggests that the major mechanism for inhibition of agonist-stimulated lipolysis by PIG-P relies on the reduction of the active portion of PKA, resulting in a lower phosphorylation and activity state of hormonesensitive lipase rather than in its direct inhibition. Additional experiments are required to discriminate between a decline of cytosolic cAMP levels and/or an inhibition of the intrinsic activity of PKA independent of the cAMP levels induced by PIG-P to lower the PKA activity ratio.
Discussion
The primary aim of the present study was to demonstrate unambiguously the insulin-mimetic activity of PIG structures as they are found within certain free glycolipids and glycolipidic membrane protein anchors. This has been discussed very controversially so far. Part of this dispute was based on lack of knowledge of the exact structure of the molecules used, their heterogeneity, a limited set of data on biological activity for a given preparation (often accompanied by modest effects, only) and problems with reproducibility of the data. These obstacles, often caused by limited amounts of substance available, have been clearly circumvented by our approach.
The PIG-P used in the present study, which has been generated from a yeast GPI-anchored protein by successive proteolytic and lipolytic cleavage, is chemically homogenous and of defined structure. It potently mimics a broad spectrum of metabolic insulin actions (i.e. stimulation of glucose transport, GLUT4 translocation, lipogenesis, GPAT, glycogenesis, GS, and inhibition of isoproterenol-induced lipolysis, PKA) in isolated fat and muscle (cardiomyocytes, diaphragm) cells. Perhaps the most challenging insulin-mimetic activity of the PIG-P represents the stimulation of glucose transport in isolated rat adipocytes, diaphragms and cardiomyocytes, because for PIG structures derived from free glycolipids controversial results have been published. PIG purified from rat liver does not modulate glucose transport in isolated rat adipocytes (52), but PIG-like molecules (although structurally ill-defined) from other sources, such as calf plasma (53) or rat adipocytes (54), activate glucose transport in this system. These discrepancies may rely on the biological source of PIG and thus ultimately on structural differences. Recent preliminary studies on the structure-activity relationship of the PIG(-P) used in the present report hint into this direction (Frick, W., A. Bauer, M. Bauer, S. Wied, G. Mü ller, manuscript in preparation). A PIG-P with a single asparagine residue left as peptide portion, which had been prepared from yeast Gce1p as described here but using pronase instead of V8 protease, or chemically synthesized PIG structures harboring the complete glycan portion of the isolated PIG-P but lacking the terminal phosphoethanolamine-peptide portion stimulate/inhibit the key enzymes of glucose metabolism (i.e. GS, GPAT, PKA) almost as efficiently as the authentic PIG-P but, in contrast to those, show very moderate or even no effect on glucose transport in isolated rat adipocytes.
The potency of the PIG-P with respect to both maximal activity and EC 50 values and its availability in sufficient quantity should enable detailed studies on its target at the molecular level in normal and desensitized adipocytes as well as in muscle cells. There are several possibilities for the molecular mechanism how PIG-P can exert pleiotropic effects on glucose transport and metabolism in insulin-sensitive cells: 1) binding of the PIG-P (perhaps via different structural determinants) to distinct cell surface receptors (which certainly do not include the insulin receptor [see Fig. 4 ] but may be identical with receptor proteins for lipolytically cleaved GPI-anchored proteins identified in plasma membranes of isolated rat adipocytes (32)); 2) after transport across the plasma membrane [which has been described for PIG molecules from rat liver after incubation with rat hepatocytes (55) ], binding of PIG-P to distinct intracellular target proteins, which are coupled to the glucose transport system (GLUT4 translocation machinery) and the individual key metabolic enzymes (GS, GPAT, hormone-sensitive lipase); 3) induction of a signaling cascade that branches to GLUT4 and the metabolic enzymes. In case of the latter mechanism and in analogy to insulin signal transduction, tyrosine phosphorylation of insulin receptor substrate-1/2 (IRS-1/2) may be the primary target of PIG-P because this seems to be prerequisite for most if not all insulin actions (for a review, see Ref. 56 ). In contrast, phosphatidylinositol-3Јkinase (PI-3Јkinase), which is located immediately downstream of IRS-1/2 in the insulin signaling cascade (56) and has to be stimulated by insulin for glucose transport activation to occur (57) , is apparently involved in some but not all metabolic insulin actions (58) . In consequence, a putative direct activation of PI-3Јkinase by PIG-P (which does not involve tyrosine phosphorylation of IRS-1/2) may not be sufficient to induce all the observed insulin-mimetic effects. Currently, we are studying the effect of PIG-P on IRS-1 and PI-3Јkinase and the participation of PI-3Јkinase in the insulin-mimetic activity of PIG-P (Eckel, J., and G. Mü ller, manuscript in preparation). Thus, knowledge of the molecular mode of PIG-P action may also provide insights into the regulation of lipid and glycogen synthesis by insulin because PIG-P and insulin may share part(s) of their signal transduction mechanisms.
The PIG-P we are using is derived from a GPI-anchored protein and harbors a phosphoethanol-peptide moiety in addition to the phosphoinositolglycan part. This molecule seems to be almost as potent as insulin in stimulating glucose transport and metabolism and significantly more effective than PIG structures derived from free glycolipids (for which insulin-dependent production in insulin-sensitive cells has been reported; for a review see Ref. 7). However, its unusual structure raises some questions on the physiological relevance because the (insulin-induced) biosynthesis would require double processing of a GPI-anchored protein. In fact, this has been speculated from previous findings that insulin causes lipolytic cleavage of some GPI-anchored proteins in cultured fat and muscle cells (see first section of this article). We confirmed this for Gce1 (which is a GPI-anchored protein homologous to yeast Gce1p) in 3T3 adipocytes (13) . In addition, we demonstrated a rapid loss of myo-inositol-phosphate from the lipolytically cleaved Gce1, indicating a secondary processing event within the residual glycan portion of the anchor or the carboxyl terminus of Gce1. However, so far there is no direct evidence for the (insulin-dependent) release of PIG-P from Gce1 (or other GPI-anchored proteins) in insulin-sensitive cells.
